Exclusive enteral nutrition: An optimal care pathway for use in adult patients with active Crohn's disease - Day - 2020 - JGH Open - Wiley Online Library
RNAO - ECCO MODEL 3.0
Conference Highlights - ECCO 2020: subcutaneous-vedolizumab-maintenance-therapy-in-cd
PDF) Outcomes and Strategies to Support a Treat-to-target Approach in Inflammatory Bowel Disease: A Systematic Review
Education
Treat to Target: A Proposed New Paradigm for the Management of Crohn's Disease - Clinical Gastroenterology and Hepatology
Acceptability of a 'treat to target' approach in inflammatory bowel disease to patients in clinical remission | Frontline Gastroenterology
New Phase 3b Interim Data from STARDUST Study Show Two-Thirds of Patients with Moderately to Severely Active Crohn's Disease Achieved Clinical Remission After Two Doses of STELARA® (ustekinumab) | Business Wire
Objective evaluation for treat to target in Crohn's disease | SpringerLink
Plus Therapeutics, Inc. Free Writing Prospectus FWP
Treat-to-Target in Pediatric Inflammatory Bowel Disease: What Does the Evidence Say? | SpringerLink
Education
TARGET-IBD Poster & Oral Presentation at ECCO
PPT - A Report from ECCO 14 Oral Chemotherapy in Colorectal Cancer PowerPoint Presentation - ID:3575065
Primary sclerosing cholangitis and inflammatory bowel disease comorbidity: an update of the evidence
PDF) ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment
PDF) ECCO Position Paper: Harmonization of the Approach to Ulcerative Colitis Histopathology
3D TARGET SRL | LinkedIn
Education
Novel Analgesics with Peripheral Targets | SpringerLink
Therapeutic targets in inflammatory bowel disease | Revista Médica Clínica Las Condes
PDF) Identification of Chitinase-3-Like Protein 1 as a Novel Neutrophil Antigenic Target in Crohn's Disease
ECCO News 3/2018
Treat-to-Target Approach in Inflammatory Bowel Disease: The Role of Advanced Practice Providers - ScienceDirect
Eco Style Professional Styling Gel Krystal - 16 Fl Oz : Target
